Clinical Trial Update: Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (ESCUDDO) evaluating one versus two doses of the human papillomavirus vaccine to prevent HPV infection and HPV-related cervical cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Human papillomavirus vaccine (human papillomavirus vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Status: ACTIVE_NOT_RECRUITING